{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:06:57Z","timestamp":1790219217904,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multimorbidity, defined here as the co-occurrence of cardiovascular disease (CVD), type 2 diabetes (T2D), and\/or cancer is a major public health challenge. However, its underlying biological mechanisms remain unclear, limiting progress toward identifying shared interventional targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We applied large-scale plasma proteomics (SomaScan 7k; 7,289 aptamers) in 13,270 European Prospective Investigation into Cancer and Nutrition (EPIC) participants to identify protein signatures of multimorbidity. We modelled multimorbidity progression as sequential disease transitions, i.e., from the disease-free state at baseline to a first disease and from the first disease to a second disease. Using weighted multivariable Cox regression, we estimated hazard ratios (HR) and 95% confidence intervals (CI) for risk of cancer, CVD, and T2D. Risk associations were replicated using Olink proteomics in UK Biobank (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200944,567).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 422 aptamers associated with more than one disease (FDR-corrected\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), e.g., 265 aptamers were shared between CVD and T2D. Thirty-eight aptamers were associated with multimorbidity progression. Among these, 27 aptamers showed consistent positive associations across sequential disease transitions, including SEMA6A (disease-free to cancer HR: 1.14; 95% CI 1.05, 1.23; cancer to T2D HR: 2.61; 95% CI 1.76, 3.80). Four aptamers showed consistent inverse associations, including NLGN1 (disease-free to T2D HR: 0.72; 95% CI 0.61, 0.84; T2D to cancer HR: 0.57; 95% CI 0.43, 0.75). Nineteen of the identified proteins were also measured in UK Biobank, with broadly consistent associations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies candidate proteins that may indicate molecular pathways to multimorbidity of cardiometabolic diseases and cancer. Future studies should evaluate the causal roles of these proteins for targeted interventions and risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03263-4","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:35:39Z","timestamp":1781951739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteomics of multimorbidity progression across cardiometabolic diseases and cancer in a multinational cohort"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-1751","authenticated-orcid":false,"given":"Michael J.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Viallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Leitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Smith-Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Ler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Ricceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Beigrezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Koop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Zamora-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jim\u00e9nez-Zabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Lill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Freisling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"3263_CR1","unstructured":"Academy of Medical Sciences. Multimorbidity: a priority for global health research: Academy of Medical Sciences. 2018 [Available from: https:\/\/acmedsci.ac.uk\/file-download\/82222577"},{"key":"3263_CR2","unstructured":"World Health Organization. Global status report on noncommunicable diseases 2014: World Health Organization. 2014 [Available from: https:\/\/iris.who.int\/handle\/10665\/148114"},{"issue":"7","key":"3263_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41591-023-02420-6","volume":"29","author":"C Langenberg","year":"2023","unstructured":"Langenberg C, Hingorani AD, Whitty CJM. Biological and functional multimorbidity\u2014from mechanisms to management. Nat Med. 2023;29(7):1649\u201357.","journal-title":"Nat Med"},{"key":"3263_CR4","doi-asserted-by":"publisher","first-page":"l6964","DOI":"10.1136\/bmj.l6964","volume":"368","author":"CJM Whitty","year":"2020","unstructured":"Whitty CJM, MacEwen C, Goddard A, Alderson D, Marshall M, Calderwood C, et al. Rising to the challenge of multimorbidity. BMJ. 2020;368:l6964.","journal-title":"BMJ"},{"issue":"4","key":"3263_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev. 2011;10(4):430\u20139.","journal-title":"Ageing Res Rev"},{"key":"3263_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.archger.2016.07.008","volume":"67","author":"BP Nunes","year":"2016","unstructured":"Nunes BP, Flores TR, Mielke GI, Thum\u00e9 E, Facchini LA. Multimorbidity and mortality in older adults: A systematic review and meta-analysis. Arch Gerontol Geriatr. 2016;67:130\u20138.","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"3263_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1077558711399580","volume":"68","author":"T Lehnert","year":"2011","unstructured":"Lehnert T, Heider D, Leicht H, Heinrich S, Corrieri S, Luppa M, et al. Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions. Med Care Res Rev. 2011;68(4):387\u2013420.","journal-title":"Med Care Res Rev"},{"issue":"10440","key":"3263_CR8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100\u201332.","journal-title":"Lancet"},{"issue":"7","key":"3263_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","volume":"25","author":"SM Bluethmann","year":"2016","unstructured":"Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the Silver Tsunami: Prevalence Trajectories and Co-Morbidity Burden among Older Cancer Survivors in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1029\u201336.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6101","key":"3263_CR10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1126\/science.1227001","volume":"337","author":"M Ezzati","year":"2012","unstructured":"Ezzati M, Riboli E. Can Noncommunicable Diseases Be Prevented? Lessons from Studies of Populations and Individuals. Science. 2012;337(6101):1482\u20137.","journal-title":"Science"},{"issue":"3","key":"3263_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1183\/09031936.00229714","volume":"45","author":"PJ Barnes","year":"2015","unstructured":"Barnes PJ. Mechanisms of development of multimorbidity in the elderly. Eur Respir J. 2015;45(3):790\u2013806.","journal-title":"Eur Respir J"},{"key":"3263_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coi.2014.03.007","volume":"29","author":"G Pawelec","year":"2014","unstructured":"Pawelec G, Goldeck D, Derhovanessian E. Inflammation, ageing and chronic disease. Curr Opin Immunol. 2014;29:23\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"3263_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/ijerph13040391","volume":"13","author":"K Agur","year":"2016","unstructured":"Agur K, McLean G, Hunt K, Guthrie B, Mercer SW. How Does Sex Influence Multimorbidity? Secondary Analysis of a Large Nationally Representative Dataset. Int J Environ Res Public Health. 2016;13(4):391.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"3263_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/eurpub\/ckz012","volume":"29","author":"WJGM Verest","year":"2019","unstructured":"Verest WJGM, Galenkamp H, Spek B, Snijder MB, Stronks K, van Valkengoed IGM. Do ethnic inequalities in multimorbidity reflect ethnic differences in socioeconomic status? The HELIUS study. Eur J Public Health. 2019;29(4):687\u201393.","journal-title":"Eur J Public Health"},{"key":"3263_CR15","unstructured":"Manfredi L, Sodano B, Raganato C, Buscema F, Milani L, Catalano A et al. A longitudinal Analysis of the Association between Socioeconomic Position and Multimorbidity in the European Prospective Investigation into Cancer and Nutrition Study. Aging Dis. 2025:0&#8211."},{"issue":"9","key":"3263_CR16","doi-asserted-by":"publisher","first-page":"e1003332","DOI":"10.1371\/journal.pmed.1003332","volume":"17","author":"YV Chudasama","year":"2020","unstructured":"Chudasama YV, Khunti K, Gillies CL, Dhalwani NN, Davies MJ, Yates T, et al. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study. PLoS Med. 2020;17(9):e1003332.","journal-title":"PLoS Med"},{"issue":"4","key":"3263_CR17","first-page":"528","volume":"72","author":"NN Dhalwani","year":"2016","unstructured":"Dhalwani NN, Zaccardi F, O\u2019Donovan G, Carter P, Hamer M, Yates T, et al. Association Between Lifestyle Factors and the Incidence of Multimorbidity in an Older English Population. Journals Gerontology: Ser A. 2016;72(4):528\u201334.","journal-title":"Journals Gerontology: Ser A"},{"key":"3263_CR18","doi-asserted-by":"publisher","first-page":"100771","DOI":"10.1016\/j.lanepe.2023.100771","volume":"35","author":"R Cordova","year":"2023","unstructured":"Cordova R, Viallon V, Fontvieille E, Peruchet-Noray L, Jansana A, Wagner K-H, et al. Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. Lancet Reg Health - Europe. 2023;35:100771.","journal-title":"Lancet Reg Health - Europe"},{"issue":"1","key":"3263_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2296-15-55","volume":"15","author":"Q Foguet-Boreu","year":"2014","unstructured":"Foguet-Boreu Q, Violan C, Roso-Llorach A, Rodriguez-Blanco T, Pons-Vigu\u00e9s M, Mu\u00f1oz-P\u00e9rez MA, et al. Impact of multimorbidity: acute morbidity, area of residency and use of health services across the life span in a region of south Europe. BMC Fam Pract. 2014;15(1):55.","journal-title":"BMC Fam Pract"},{"issue":"10","key":"3263_CR20","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/s42255-024-01133-5","volume":"6","author":"J Carrasco-Zanini","year":"2024","unstructured":"Carrasco-Zanini J, Wheeler E, Uluvar B, Kerrison N, Koprulu M, Wareham NJ, et al. Mapping biological influences on the human plasma proteome beyond the genome. Nat Metabolism. 2024;6(10):2010\u201323.","journal-title":"Nat Metabolism"},{"issue":"1","key":"3263_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-025-02670-3","volume":"24","author":"Y Li","year":"2025","unstructured":"Li Y, Li D, Lin J, Zhou L, Yang W, Yin X, et al. Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease. Cardiovasc Diabetol. 2025;24(1):120.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"3263_CR22","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41591-024-03142-z","volume":"30","author":"J Carrasco-Zanini","year":"2024","unstructured":"Carrasco-Zanini J, Pietzner M, Davitte J, Surendran P, Croteau-Chonka DC, Robins C, et al. Proteomic signatures improve risk prediction for common and rare diseases. Nat Med. 2024;30(9):2489\u201398.","journal-title":"Nat Med"},{"issue":"suppl1","key":"3263_CR23","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","volume":"26","author":"E Riboli","year":"1997","unstructured":"Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26(suppl1):S6\u2013S.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"3263_CR24","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, et al. Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery. PLoS ONE. 2010;5(12):e15004.","journal-title":"PLoS ONE"},{"issue":"2","key":"3263_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10654-006-9096-8","volume":"22","author":"J Danesh","year":"2007","unstructured":"Danesh J, Saracci R, Berglund G, Feskens E, Overvad K, Panico S, et al. EPIC-Heart: The cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007;22(2):129\u201341.","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"3263_CR26","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s00125-011-2182-9","volume":"54","author":"The InterAct Consortium","year":"2011","unstructured":"The InterAct Consortium. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 2011;54(9):2272\u201382.","journal-title":"Diabetologia"},{"issue":"6","key":"3263_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i06","volume":"38","author":"B Carstensen","year":"2011","unstructured":"Carstensen B, Plummer M. Using Lexis Objects for Multi-State Models in R. J Stat Softw. 2011;38(6):1\u201318.","journal-title":"J Stat Softw"},{"issue":"4","key":"3263_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3945\/ajcn.2010.29482","volume":"92","author":"D Romaguera","year":"2010","unstructured":"Romaguera D, Norat T, Vergnaud A-C, Mouw T, May AM, Agudo A, et al. Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project123. Am J Clin Nutr. 2010;92(4):912\u201321.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"3263_CR29","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"7982","key":"3263_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329\u201338.","journal-title":"Nature"},{"issue":"7982","key":"3263_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, Helgason H, Magnusson OT, Gunnarsdottir K, et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023;622(7982):348\u201358.","journal-title":"Nature"},{"key":"3263_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies. With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"FE Harrell","year":"2015","unstructured":"Harrell FE. Regression Modeling Strategies. With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2nd ed. Cham: Springer; 2015.","edition":"2"},{"issue":"1","key":"3263_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/biomet\/79.1.139","volume":"79","author":"DA Binder","year":"1992","unstructured":"Binder DA. Fitting Cox\u2019s Proportional Hazards Models from Survey Data. Biometrika. 1992;79(1):139\u201347.","journal-title":"Biometrika"},{"key":"3263_CR34","doi-asserted-by":"publisher","first-page":"100080","DOI":"10.1016\/j.gloepi.2022.100080","volume":"4","author":"MA Mansournia","year":"2022","unstructured":"Mansournia MA, Nazemipour M, Etminan M. A practical guide to handling competing events in etiologic time-to-event studies. Global Epidemiol. 2022;4:100080.","journal-title":"Global Epidemiol"},{"issue":"1","key":"3263_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Methodol. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"issue":"1","key":"3263_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"D1","key":"3263_CR37","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2015","unstructured":"Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2015;44(D1):D457\u201362.","journal-title":"Nucleic Acids Res"},{"key":"3263_CR38","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2022 [cited 2024 Oct 14]. Available from: https:\/\/www.R-project.org\/"},{"key":"3263_CR39","unstructured":"Harrell F. rms: Regression Modeling Strategies. R package version 6.3-0 2022 [Available from: https:\/\/CRAN.R-project.org\/package=rms"},{"issue":"12","key":"3263_CR40","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/ejhg.2009.86","volume":"17","author":"W Chen","year":"2009","unstructured":"Chen W, Wang S, Tian T, Bai J, Hu Z, Xu Y, et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Eur J Hum Genet. 2009;17(12):1668\u201375.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"3263_CR41","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and Cancer: A consensus report. Diabetes Care. 2010;33(7):1674\u201385.","journal-title":"Diabetes Care"},{"issue":"9418","key":"3263_CR42","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","volume":"363","author":"AG Renehan","year":"2004","unstructured":"Renehan AG, Zwahlen M, Minder C, O\u2019Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346\u201353.","journal-title":"Lancet"},{"issue":"8","key":"3263_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3263_CR44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Investig. 2006;116(7):1793\u2013801.","journal-title":"J Clin Investig"},{"key":"3263_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.atherosclerosis.2017.06.001","volume":"263","author":"F Masoudkabir","year":"2017","unstructured":"Masoudkabir F, Sarrafzadegan N, Gotay C, Ignaszewski A, Krahn AD, Davis MK, et al. Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017;263:343\u201351.","journal-title":"Atherosclerosis"},{"key":"3263_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.biopha.2017.10.122","volume":"97","author":"J-y Chen","year":"2018","unstructured":"Chen J-y, Ye Z-x, Wang X-f, Chang J, Yang M-w, Zhong H-h, et al. Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomed Pharmacother. 2018;97:423\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3263_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/procel\/pwaf072","volume":"17","author":"Y-L Chen","year":"2026","unstructured":"Chen Y-L, Wang J-J, You J, Cheng J-Y, Li Z-Y, Ge Y-J, et al. Systematic analyses uncover plasma proteins linked to incident cardiovascular diseases. Protein Cell. 2026;17(3):231\u201347.","journal-title":"Protein Cell"},{"issue":"10","key":"3263_CR48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrm1740","volume":"6","author":"RP Kruger","year":"2005","unstructured":"Kruger RP, Aurandt J, Guan K-L. Semaphorins command cells to move. Nat Rev Mol Cell Biol. 2005;6(10):789\u2013800.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"23","key":"3263_CR49","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.3390\/cancers15235536","volume":"15","author":"W Wagner","year":"2023","unstructured":"Wagner W, Ochman B, Wagner W. Semaphorin 6 Family\u2014An Important Yet Overlooked Group of Signaling Proteins Involved in Cancerogenesis. Cancers (Basel). 2023;15(23):5536.","journal-title":"Cancers (Basel)"},{"issue":"16","key":"3263_CR50","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.3390\/ijms21165641","volume":"21","author":"Q Lu","year":"2020","unstructured":"Lu Q, Zhu L. The Role of Semaphorins in Metabolic Disorders. Int J Mol Sci. 2020;21(16):5641.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3263_CR51","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ajh.2012.88","volume":"25","author":"H Ota","year":"2012","unstructured":"Ota H, Furuhashi M, Ishimura S, Koyama M, Okazaki Y, Mita T, et al. Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation. Am J Hypertens. 2012;25(10):1124\u201330.","journal-title":"Am J Hypertens"},{"issue":"10","key":"3263_CR52","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2337\/dc07-0413","volume":"30","author":"AWK Tso","year":"2007","unstructured":"Tso AWK, Xu A, Sham PC, Wat NMS, Wang Y, Fong CHY, et al. Serum Adipocyte Fatty Acid\u2013Binding Protein as a New Biomarker Predicting the Development of Type 2 Diabetes: A 10-year prospective study in a Chinese cohort. Diabetes Care. 2007;30(10):2667\u201372.","journal-title":"Diabetes Care"},{"issue":"1","key":"3263_CR53","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-023-05011-w","volume":"6","author":"JD Garritson","year":"2023","unstructured":"Garritson JD, Zhang J, Achenbach A, Ferhat M, Eich E, Stubben CJ, et al. BMPER is a marker of adipose progenitors and adipocytes and a positive modulator of adipogenesis. Commun Biol. 2023;6(1):638.","journal-title":"Commun Biol"},{"issue":"24","key":"3263_CR54","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/onc.2011.473","volume":"31","author":"J Heinke","year":"2012","unstructured":"Heinke J, Kerber M, Rahner S, Mnich L, Lassmann S, Helbing T, et al. Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior. Oncogene. 2012;31(24):2919\u201330.","journal-title":"Oncogene"},{"issue":"1","key":"3263_CR55","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41419-025-07929-x","volume":"16","author":"Y Duan","year":"2025","unstructured":"Duan Y, Li P, Yang Y, Wu G, Xing H, Chen H, et al. EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription. Cell Death Dis. 2025;16(1):605.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3263_CR56","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/cas.16417","volume":"116","author":"Y Chen","year":"2025","unstructured":"Chen Y, Pan G, Yang Y, Wu H, Weng M, Wu Q, et al. Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer-associated fibroblast activation. Cancer Sci. 2025;116(3):792\u2013807.","journal-title":"Cancer Sci"},{"issue":"3","key":"3263_CR57","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imm.12042","volume":"138","author":"ASG O\u2019Neill","year":"2013","unstructured":"O\u2019Neill ASG, van den Berg TK, Mullen GED. Sialoadhesin \u2013 a macrophage-restricted marker of immunoregulation and inflammation. Immunology. 2013;138(3):198\u2013207.","journal-title":"Immunology"},{"issue":"2","key":"3263_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.metabol.2015.10.001","volume":"65","author":"EC Graff","year":"2016","unstructured":"Graff EC, Fang H, Wanders D, Judd RL. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism. 2016;65(2):102\u201313.","journal-title":"Metabolism"},{"key":"3263_CR59","doi-asserted-by":"crossref","unstructured":"Kew RR. The Vitamin D Binding Protein and Inflammatory Injury: A Mediator or Sentinel of Tissue Damage? Front Endocrinol (Lausanne). 2019;Volume 10\u20132019.","DOI":"10.3389\/fendo.2019.00470"},{"issue":"1","key":"3263_CR60","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1038\/s41467-020-17468-y","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang C, Eleftheriadou M, Kelaini S, Morrison T, Gonz\u00e1lez MV, Caines R, et al. Targeting QKI-7 in vivo restores endothelial cell function in diabetes. Nat Commun. 2020;11(1):3812.","journal-title":"Nat Commun"},{"issue":"1","key":"3263_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-018-0453-1","volume":"25","author":"RF Hillary","year":"2018","unstructured":"Hillary RF, FitzGerald U. A lifetime of stress: ATF6 in development and homeostasis. J Biomed Sci. 2018;25(1):48.","journal-title":"J Biomed Sci"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03263-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:15:54Z","timestamp":1782209754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3263"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03263-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval in EPIC was obtained from the Ethical Review Boards of the IARC and the Institutional Review Board of each participating EPIC center. Written informed consent was obtained from all participants. In UK Biobank, ethical approval was obtained from the North West Multi-Centre Research Ethics Committee and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}